Ireland
--:--IST
Starting soon Not applicable

High Power Laser Therapy for Herniated Disc and Lumbosacral Radiculopathy

NCT06831227 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2025-03-01
Last updated
2025-02-18

Condition(s) studied

Herniated Lumbar Disc

Investigational drug(s) / intervention(s)

High power Laser Therapyphysical therapy exercise program and hot pack

High power Laser Therapy: A total course protocol: 18 sessions, for 6 weeks ,3 sessions per week. Patients will receive High power Laser treatment. manually set to bio stimulation mode with high peak power (5 - 6 W), energy per impulse 150 mJ/c2, wavelength measuring 1064 nm, and spot beam diameter area of 1 cm2. The hand piece was positioned in contact with and perpendicular to the treated area with the patient inside lying position with knee to chest. Scanning will perform transversely and longitudinally paravertebral region on the lower lumbar area at the level of the disc concerned. Each session included three phases (fast scan, sensitive trigger points, slow scan) and had a total duration of 20 minutes. During each session, a total energy of 3000 J was applied through three phases of treatment.

physical therapy exercise program and hot pack: this group will receive the same selected physical therapy exercise program (45 minutes) and hot pack (10 min) for 18 session. All patients will attend the physical therapy clinic three times weekly for 6 weeks

Study summary

To determine the effect of high-power laser therapy on the size of herniated disc and functional outcome in patients with lumbosacral radiculopathy.

Eligibility

Sex
ALL
Min age
30 Years
Max age
45 Years
Healthy volunteers
No
Inclusion Criteria: * Patients diagnosed by orthopedic or neurological consultants depended on MRI assessment as disc herniation (L4-L5/L5-S1levels) with lumbar radiculopathy. * patients from both genders. * The patient age will range from 30-45 years old. * Duration of illness ranged from 3 to 6 months. * All patients in the study should be ambulant independently. * Medically and psychologically stable patients. Exclusion Criteria: * Previous lumbar or hip surgery. * Cauda equina syndrome * Fracture of the bones of lower extremity. * Major neurological condition (e.g., stroke, multiple sclerosis, Epilepsy, Meningitis, and Brain tumor). * BMI not more than 30. * Vascular Impairment. * Pregnancy and Gynecological problems * Red flags: spinal tumors, spinal fractures, osteoporosis, infection.

Primary outcome measure(s)

  • Visual Analogue Scale (VAS) — 3 to 6 months
    Visual Analogue Scale (VAS): This scale is used to assess the severity of pain. It consists of a line, usually 10 cm long, ranging from no pain or discomfort (zero) to the worst pain (10) that the patient could feel
  • Back Pain Related Disability (ODI) using Oswestry low back pain disability questionnaire — 3-6 months
    Modified Oswestry low back disability questionnaire will be used to evaluate patient functional disability. It consists of 10 sections of activities of daily life. Patient asked to answer by checking ONE box in each section for the statement which best applies to her. For each section the total possible score is 5: if the first statement is marked the section score = 0; if the last statement is marked, it = 5.

Trial sites (1)

FacilityCityRegionStatus
Faculty of Physical Therapy Giza Egypt
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06831227 on ClinicalTrials.gov ↗ ← All trials in Egypt